Treating infections with ionizing radiation: a historical perspective and emerging techniques

Abstract

Background: Widespread use and misuse of antibiotics have led to a dramatic increase in the emergence of antibiotic resistant bacteria, while the discovery and development of new antibiotics is declining. This has made certain implant-associated infections such as periprosthetic joint infections, where a biofilm is formed, very difficult to treat. Alternative treatment modalities are needed to treat these types of infections in the future. One candidate that has been used extensively in the past, is the use of ionizing radiation. This review aims to provide a historical overview and future perspective of radiation therapy in infectious diseases with a focus on orthopedic infections. Methods: A systematic search strategy was designed to select studies that used radiation as treatment for bacterial or fungal infections. A total of 216 potentially relevant full-text publications were independently reviewed, of which 182 focused on external radiation and 34 on internal radiation. Due to the large number of studies, several topics were chosen. The main advantages, disadvantages, limitations, and implications of radiation treatment for infections were discussed. Results: In the pre-antibiotic era, high mortality rates were seen in different infections such as pneumonia, gas gangrene and otitis media. In some cases, external radiation therapy decreased the mortality significantly but longterm follow-up of the patients was often not performed so long term radiation effects, as well as potential increased risk of malignancies could not be investigated. Internal radiation using alpha and beta emitting radionuclides show great promise in treating fungal and bacterial infections when combined with selective targeting through antibodies, thus minimizing possible collateral damage to healthy tissue. Conclusion: The novel prospects of radiation treatment strategies against planktonic and biofilm-related microbial infections seem feasible and are worth investigating further. However, potential risks involving radiation treatment must be considered in each individual patient.

Novel Human Antibodies to Insulin Growth Factor 2 Receptor (IGF2R) for Radioimmunoimaging and Therapy of Canine and Human Osteosarcoma

“…The mAbs were radiolabeled with 111 In and used in biodistribution and imaging experiments as described in [ 12 ]. IGF2R-Fab1 was conjugated with 10 M excess p-SCN-Bn-DOTA as in [ 12 ] and radiolabeled with 225 Ac for in vitro cell killing as in [ 22 ]. Briefly, 225 Ac chloride was diluted with 0.15 M NH 4 acetate buffer and added to the Fab1-DOTA conjugate in the same buffer in a volume of ~35 μL.…”

Revisiting the Radiobiology of Targeted Alpha Therapy

“…Another attractive field actually supporting a more integrated view of radiobiology is the use of TAT to overcome resistance to medications of fungal or bacterial infections (81)(82)(83)(84). Although bacteria do not present a nucleus as eukaryotic cancer cells, 213 Bi-MAb D11 directed against pneumococcal capsular polysaccharide 8 (PPS8) was able to efficiently kill Streptococcus pneumoniae in vitro and to reduce bacterial load in C57BL/6 mice (81).…”

Non-linear association of cystatin C and all-cause mortality of heart failure: A secondary analysis based on a published database

“…HF not only causes serious physical and psychological impairment to sufferers, but it also places a financial strain on society as a whole ( 4 ). According to epidemiological statistics from Western nations, the 5-year death rate of HF is significantly greater than that of several cancers ( 5 ). In China, the prevalence of HF has grown sixfold in the last ten years.…”